The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Steven I. Sherman

Department of Endocrine Neoplasia and Hormonal Disorders

The University of Texas MD Anderson Cancer Center

Houston

TX 77030

USA

[email]@mdanderson.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 1999 - 2011
  • The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1432, Houston, USA. 2010

References

  1. Targeted therapies for thyroid tumors. Sherman, S.I. Mod. Pathol. (2011) [Pubmed]
  2. Targeted therapy of thyroid cancer. Sherman, S.I. Biochem. Pharmacol. (2010) [Pubmed]
  3. Cytotoxic chemotherapy for differentiated thyroid carcinoma. Sherman, S.I. Clin. Oncol. (R. Coll. Radiol) (2010) [Pubmed]
  4. Tyrosine kinase inhibitors and the thyroid. Sherman, S.I. Best Pract. Res. Clin. Endocrinol. Metab. (2009) [Pubmed]
  5. Molecularly targeted therapies for thyroid cancers. Sherman, S.I. Endocr. Pract (2009) [Pubmed]
  6. Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers. Sherman, S.I. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  7. Motesanib diphosphate in progressive differentiated thyroid cancer. Sherman, S.I., Wirth, L.J., Droz, J.P., Hofmann, M., Bastholt, L., Martins, R.G., Licitra, L., Eschenberg, M.J., Sun, Y.N., Juan, T., Stepan, D.E., Schlumberger, M.J. N. Engl. J. Med. (2008) [Pubmed]
  8. Early clinical studies of novel therapies for thyroid cancers. Sherman, S.I. Endocrinol. Metab. Clin. North Am. (2008) [Pubmed]
  9. Can serum thyroglobulin levels predict patient outcome after treatment of differentiated thyroid carcinoma?. Sherman, S.I. Nature Clinical Practice. Endocrinology & Metabolism (2007) [Pubmed]
  10. Thyroid carcinoma. Sherman, S.I. Lancet (2003) [Pubmed]
  11. Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma. Sherman, S.I. Clin. Lymphoma (2003) [Pubmed]
  12. The management of metastatic differentiated thyroid carcinoma. Sherman, S.I. Rev. Endocr. Metab. Disord (2000) [Pubmed]
  13. Central hypothyroidism associated with retinoid X receptor-selective ligands. Sherman, S.I., Gopal, J., Haugen, B.R., Chiu, A.C., Whaley, K., Nowlakha, P., Duvic, M. N. Engl. J. Med. (1999) [Pubmed]
  14. Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma. Sherman, S.I. Semin. Surg. Oncol (1999) [Pubmed]
  15. Adjuvant therapy and long-term management of differentiated thyroid carcinoma. Sherman, S.I. Semin. Surg. Oncol (1999) [Pubmed]
 
WikiGenes - Universities